Clinical Trial Update: Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]

View source ↗

Summary

The Phase 1 trial evaluating sirolimus in combination with a vaccine therapy for stage II-IV ovarian, fallopian tube, or primary peritoneal cancer has been with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma | Phase 1 | Status: WITHDRAWN